Robert Lakin

Robert Lakin

InvestorPlace Contributor

A journalist — both writer and editor — Robert has covered markets and economies for more than 20 years. His previous gigs include Bloomberg News, where he was emerging markets editor in Tel Aviv, McKinsey & Co. and McDonald & Company Investments, where he was equities research editor.

His deep experience includes covering startups, emerging markets, financial services, and capital markets.

He writes a Substack newsletter, TLV Strategist, which covers the Israel business scene.

Recent Articles

CVS Customers Stock Up as USPS Delays Expose Pharmacy Mail Prescription Risks

By Robert Lakin, InvestorPlace Contributor

Delays in U.S. Postal Service deliveries have exposed the dangers of prescription drug mail order services. Walgreens has reported some delays in home deliveries as CVS allows customers to stock up.

Telehealth Services Set to Grow in Wake of Pandemic

By Robert Lakin, InvestorPlace Contributor

NYU Langone Health reported urgent virtual telehealth visits increasing by 683% between March and April 2020.

DraftKings, FanDuel Entry Fees Declared Taxable by IRS

By Robert Lakin, InvestorPlace Contributor

DraftKings, FanDuel and other similar daily fantasy sports companies must pay federal excise tax on their entry fees, the IRS ruled. DKNG stock fell after the fantasy sports firm reported disappointing earnings.

Retailers’ Healthcare Ventures Momentum Not Shaken by Departures

By Robert Lakin, InvestorPlace Contributor

Recent senior staff turnover at a number of retailer-based healthcare ventures, including Walmart doesn't change analysts' outlook for the efforts. WMT stock investors have a keen interest in developments.

Invest in Millennial Fertility Stock to Make Pregnancy Accessible

By Robert Lakin, InvestorPlace Contributor

Traditional fertility treatments are super expensive and hard to access. Invest in Millennial Fertility stock to make pregnancy accessible.

Load More